Jonathan M. Blevitt

1.8k total citations
23 papers, 1.3k citations indexed

About

Jonathan M. Blevitt is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Jonathan M. Blevitt has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Pharmacology. Recurrent topics in Jonathan M. Blevitt's work include Eicosanoids and Hypertension Pharmacology (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Receptor Mechanisms and Signaling (4 papers). Jonathan M. Blevitt is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Receptor Mechanisms and Signaling (4 papers). Jonathan M. Blevitt collaborates with scholars based in United States, Thailand and Israel. Jonathan M. Blevitt's co-authors include Larry Gerace, Xiaojun Ma, Jayashree Pyati, Xiaobing Li, Changlu Liu, Wenying Chai, Claudia L. Hofstra, Timothy W. Lovenberg, Xiaoxia Jiang and Sandy J. Wilson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Jonathan M. Blevitt

22 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan M. Blevitt United States	13	888	462	181	152	139	23	1.3k
Kenichi Higashino Japan	24	775 0.9×	420 0.9×	199 1.1×	287 1.9×	115 0.8×	35	1.6k
Richard T. Pickard United States	14	536 0.6×	449 1.0×	189 1.0×	122 0.8×	176 1.3×	20	1.3k
Urs Lewandrowski Germany	23	1.0k 1.2×	142 0.3×	229 1.3×	111 0.7×	113 0.8×	35	1.8k
Roberto Bresciani Italy	19	919 1.0×	300 0.6×	372 2.1×	278 1.8×	91 0.7×	52	1.3k
Ronald J. Uhing United States	20	1.1k 1.2×	335 0.7×	283 1.6×	220 1.4×	165 1.2×	33	1.7k
Karim Rezaul United States	15	1.1k 1.2×	354 0.8×	198 1.1×	122 0.8×	165 1.2×	22	1.5k
Eva E. Prieschl Austria	19	1.6k 1.8×	654 1.4×	309 1.7×	226 1.5×	202 1.5×	26	2.2k
Arne C. Rufer Switzerland	20	1.1k 1.2×	382 0.8×	67 0.4×	117 0.8×	106 0.8×	33	1.6k
Guy Werlen United States	18	972 1.1×	1.3k 2.8×	143 0.8×	71 0.5×	427 3.1×	27	2.1k
Mark Glover United Kingdom	15	1.3k 1.5×	195 0.4×	110 0.6×	69 0.5×	146 1.1×	23	1.7k

Countries citing papers authored by Jonathan M. Blevitt

Since Specialization

Citations

This map shows the geographic impact of Jonathan M. Blevitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan M. Blevitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan M. Blevitt more than expected).

Fields of papers citing papers by Jonathan M. Blevitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan M. Blevitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan M. Blevitt. The network helps show where Jonathan M. Blevitt may publish in the future.

Co-authorship network of co-authors of Jonathan M. Blevitt

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan M. Blevitt. A scholar is included among the top collaborators of Jonathan M. Blevitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan M. Blevitt. Jonathan M. Blevitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ehrenkaufer, Gretchen, et al.. (2023). High-throughput phenotypic screen identifies a new family of potent anti-amoebic compounds. PLoS ONE. 18(5). e0280232–e0280232. 1 indexed citations

Myagmar, Bat‐Erdene, Philip M. Swigart, Anthony J. Baker, et al.. (2019). Coupling to Gq Signaling Is Required for Cardioprotection by an Alpha-1A-Adrenergic Receptor Agonist. Circulation Research. 125(7). 699–706. 7 indexed citations

Myagmar, Bat‐Erdene, Philip M. Swigart, Anthony J. Baker, et al.. (2018). Coupling to Gq Signaling Is Required for Cardioprotection by an Alpha-1A-Adrenergic Receptor Agonist. Journal of Molecular and Cellular Cardiology. 124. 101–101.

Castro, Glenda, Xuejun Liu, Karen Ngo, et al.. (2017). RORγt and RORα signature genes in human Th17 cells. PLoS ONE. 12(8). e0181868–e0181868. 110 indexed citations

Blevitt, Jonathan M., Michael D. Hack, Krystal Herman, et al.. (2017). Structural Basis of Small-Molecule Aggregate Induced Inhibition of a Protein–Protein Interaction. Journal of Medicinal Chemistry. 60(8). 3511–3517. 53 indexed citations

Blevitt, Jonathan M., Michael D. Hack, Krystal Herman, et al.. (2016). A Single Amino Acid Difference between Mouse and Human 5-Lipoxygenase Activating Protein (FLAP) Explains the Speciation and Differential Pharmacology of Novel FLAP Inhibitors. Journal of Biological Chemistry. 291(24). 12724–12731. 12 indexed citations

Song, Jiao, Xuejun Liu, Jian Zhu, et al.. (2015). Polypharmacology of Small-Molecule Modulators of the 5-Lipoxygenase Activating Protein (FLAP) Observed via a High-throughput Lipidomics Platform. SLAS DISCOVERY. 21(2). 127–135. 4 indexed citations

Song, Jiao, Xuejun Liu, Tadimeti S. Rao, et al.. (2015). Phenotyping drug polypharmacology via eicosanoid profiling of blood. Journal of Lipid Research. 56(8). 1492–1500. 12 indexed citations

Song, Jiao, Xuejun Liu, Jiejun Wu, et al.. (2012). A highly efficient, high-throughput lipidomics platform for the quantitative detection of eicosanoids in human whole blood. Analytical Biochemistry. 433(2). 181–188. 47 indexed citations

10.

Blevitt, Jonathan M., Christa C. Chrovian, Shelby Crawford, et al.. (2012). Azabenzthiazole inhibitors of leukotriene A4 hydrolase. Bioorganic & Medicinal Chemistry Letters. 22(24). 7504–7511. 12 indexed citations

11.

Venable, Jennifer D., Michael K. Ameriks, Jonathan M. Blevitt, Robin L. Thurmond, & Wai‐Ping Fung‐Leung. (2009). Phosphoinositide 3-Kinase Gamma (PI3Kγ) Inhibitors for the Treatment of Inflammation and Autoimmune Disease. Recent Patents on Inflammation & Allergy Drug Discovery. 4(1). 1–15. 23 indexed citations

12.

LaMontagne, Kenneth R., Jeannene Butler, Virna Borowski, et al.. (2009). A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivo. Angiogenesis. 12(3). 287–296. 8 indexed citations

13.

Wolin, Ronald, Scott D. Bembenek, Jianmei Wei, et al.. (2008). Dual binding site inhibitors of B-RAF kinase. Bioorganic & Medicinal Chemistry Letters. 18(9). 2825–2829. 9 indexed citations

14.

Crawford, Shelby, Jianmei Wei, Jason P. Riley, et al.. (2008). A novel B-RAF inhibitor blocks interleukin-8 (IL-8) synthesis in human melanoma xenografts, revealing IL-8 as a potential pharmacodynamic biomarker. Molecular Cancer Therapeutics. 7(3). 492–499. 24 indexed citations

15.

Blevitt, Jonathan M., Frank U. Axe, Michael D. Hack, et al.. (2007). 2-Aryl benzimidazoles featuring alkyl-linked pendant alcohols and amines as inhibitors of checkpoint kinase Chk2. Bioorganic & Medicinal Chemistry Letters. 17(23). 6467–6471. 32 indexed citations

16.

Liu, Changlu, Xiaojun Ma, Xiaoxia Jiang, et al.. (2001). Cloning and Pharmacological Characterization of a Fourth Histamine Receptor (H₄) Expressed in Bone Marrow. Molecular Pharmacology. 59(3). 420–426. 355 indexed citations

17.

Liu, Changlu, Xiaojun Ma, Xiaoxia Jiang, et al.. (2001). Cloning and Pharmacological Characterization of a Fourth Histamine Receptor (H4) Expressed in Bone Marrow. Molecular Pharmacology. 59(3). 420–426. 42 indexed citations

18.

Blevitt, Jonathan M., et al.. (1999). A Fluorescence-Based High Throughput Screen for the Transporter Associated with Antigen Processing. SLAS DISCOVERY. 4(2). 87–91. 6 indexed citations

19.

Guan, T, Sabina Müller, George Klier, et al.. (1995). Structural analysis of the p62 complex, an assembly of O-linked glycoproteins that localizes near the central gated channel of the nuclear pore complex.. Molecular Biology of the Cell. 6(11). 1591–1603. 134 indexed citations

20.

Harasaki, H., Michael A. Jones, Jonathan M. Blevitt, et al.. (1995). Accelerated healing of cardiovascular textiles promoted by an RGD peptide.. PubMed. 4 Suppl 1. S90–7. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact